Health Canada
- Status: approved
🇨🇦 Benfotiamine 1050mg, 3 days in Canada
Benfotiamine 1050mg, 3 days (Benfotiamine 1050mg, 3 days) regulatory status in Canada.
Marketing authorisation
Benfotiamine 1050mg, 3 days in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Benfotiamine 1050mg, 3 days approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Benfotiamine 1050mg, 3 days in Canada?
Ruhr University of Bochum is the originator. The local marketing authorisation holder may differ — check the official source linked above.